Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 17:21:42 UTC
Update Date2021-09-26 23:12:43 UTC
HMDB IDHMDB0256779
Secondary Accession NumbersNone
Metabolite Identification
Common NamePritelivir
DescriptionPritelivir belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond. Based on a literature review very few articles have been published on Pritelivir. This compound has been identified in human blood as reported by (PMID: 31557052 ). Pritelivir is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Pritelivir is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
PritelivirMeSH
N-(5-(Aminiosulfonyl)-4-methyl-1,3-thiazol-2-yl)-N-methyl-2-(4-(2-pyridinyl)phenyl)acetamideMeSH
N-Methyl-N-(4-methyl-5-sulphamoyl-1,3-thiazol-2-yl)-2-[4-(pyridin-2-yl)phenyl]acetamideGenerator
Chemical FormulaC18H18N4O3S2
Average Molecular Weight402.49
Monoisotopic Molecular Weight402.082032804
IUPAC NameN-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-2-[4-(pyridin-2-yl)phenyl]acetamide
Traditional NameN-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-2-[4-(pyridin-2-yl)phenyl]acetamide
CAS Registry NumberNot Available
SMILES
CN(C(=O)CC1=CC=C(C=C1)C1=CC=CC=N1)C1=NC(C)=C(S1)S(N)(=O)=O
InChI Identifier
InChI=1S/C18H18N4O3S2/c1-12-17(27(19,24)25)26-18(21-12)22(2)16(23)11-13-6-8-14(9-7-13)15-5-3-4-10-20-15/h3-10H,11H2,1-2H3,(H2,19,24,25)
InChI KeyIVZKZONQVYTCKC-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassPyridines and derivatives
Sub ClassPhenylpyridines
Direct ParentPhenylpyridines
Alternative Parents
Substituents
  • 2-phenylpyridine
  • Phenylacetamide
  • 2,4,5-trisubstituted 1,3-thiazole
  • Monocyclic benzene moiety
  • Organosulfonic acid amide
  • Benzenoid
  • Heteroaromatic compound
  • Azole
  • Organic sulfonic acid or derivatives
  • Aminosulfonyl compound
  • Thiazole
  • Tertiary carboxylic acid amide
  • Sulfonyl
  • Organosulfonic acid or derivatives
  • Carboxamide group
  • Carboxylic acid derivative
  • Azacycle
  • Organopnictogen compound
  • Organic oxygen compound
  • Organosulfur compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organic oxide
  • Carbonyl group
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP2.37ALOGPS
logP1.97ChemAxon
logS-4.5ALOGPS
pKa (Strongest Acidic)8.58ChemAxon
pKa (Strongest Basic)4.42ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area106.25 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity101.96 m³·mol⁻¹ChemAxon
Polarizability41.27 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+187.46530932474
DeepCCS[M-H]-185.10730932474
DeepCCS[M-2H]-218.67330932474
DeepCCS[M+Na]+193.90130932474
AllCCS[M+H]+193.832859911
AllCCS[M+H-H2O]+191.032859911
AllCCS[M+NH4]+196.432859911
AllCCS[M+Na]+197.132859911
AllCCS[M-H]-191.932859911
AllCCS[M+Na-2H]-192.232859911
AllCCS[M+HCOO]-192.632859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.5.04 minutes32390414
Predicted by Siyang on May 30, 202210.6885 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20222.19 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1749.3 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid209.2 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid161.0 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid166.0 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid110.6 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid344.6 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid426.5 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)237.5 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid922.6 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid295.3 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1087.3 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid252.4 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid280.8 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate305.5 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA250.9 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water116.7 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
PritelivirCN(C(=O)CC1=CC=C(C=C1)C1=CC=CC=N1)C1=NC(C)=C(S1)S(N)(=O)=O5057.7Standard polar33892256
PritelivirCN(C(=O)CC1=CC=C(C=C1)C1=CC=CC=N1)C1=NC(C)=C(S1)S(N)(=O)=O3578.7Standard non polar33892256
PritelivirCN(C(=O)CC1=CC=C(C=C1)C1=CC=CC=N1)C1=NC(C)=C(S1)S(N)(=O)=O3859.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Pritelivir,1TMS,isomer #1CC1=C(S(=O)(=O)N[Si](C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N13692.7Semi standard non polar33892256
Pritelivir,1TMS,isomer #1CC1=C(S(=O)(=O)N[Si](C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N13457.5Standard non polar33892256
Pritelivir,1TMS,isomer #1CC1=C(S(=O)(=O)N[Si](C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N14897.2Standard polar33892256
Pritelivir,2TMS,isomer #1CC1=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N13616.4Semi standard non polar33892256
Pritelivir,2TMS,isomer #1CC1=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N13625.9Standard non polar33892256
Pritelivir,2TMS,isomer #1CC1=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N14713.5Standard polar33892256
Pritelivir,1TBDMS,isomer #1CC1=C(S(=O)(=O)N[Si](C)(C)C(C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N13901.5Semi standard non polar33892256
Pritelivir,1TBDMS,isomer #1CC1=C(S(=O)(=O)N[Si](C)(C)C(C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N13701.9Standard non polar33892256
Pritelivir,1TBDMS,isomer #1CC1=C(S(=O)(=O)N[Si](C)(C)C(C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N14841.9Standard polar33892256
Pritelivir,2TBDMS,isomer #1CC1=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N14001.6Semi standard non polar33892256
Pritelivir,2TBDMS,isomer #1CC1=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N14084.7Standard non polar33892256
Pritelivir,2TBDMS,isomer #1CC1=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)SC(N(C)C(=O)CC2=CC=C(C3=CC=CC=N3)C=C2)=N14652.3Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Pritelivir GC-MS (Non-derivatized) - 70eV, Positivesplash10-014i-0911000000-e493a87a3d6f61f05a372021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Pritelivir GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pritelivir 10V, Positive-QTOFsplash10-0pb9-0492500000-c1f9eccfa23f2763234c2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pritelivir 20V, Positive-QTOFsplash10-052f-0931000000-c4a97945847dc3fbeb232017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pritelivir 40V, Positive-QTOFsplash10-004i-0900000000-cca18782676148793cc02017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pritelivir 10V, Negative-QTOFsplash10-0udi-0104900000-fc583063dd08d087e61b2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pritelivir 20V, Negative-QTOFsplash10-00di-1519000000-aa0afcbd8341fad855612017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pritelivir 40V, Negative-QTOFsplash10-004j-9410000000-467e70d7b9f49c848c642017-07-26Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB11844
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID430613
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkPritelivir
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]